Skip to main content
SpringerLink
Log in

Erlotinib

Fatal interstitial lung disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lind JSW, Smit EF, Grünberg K, Senan S, Lagerwaard FJ.Fatal interstitial lung disease after erlotinib for non-small cell lung cancer. Journal of Thoracic Oncology 3: 1050-1053, No. 9, Sep 2008 - Netherlands

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erlotinib. React. Wkly. 1223, 11 (2008). https://doi.org/10.2165/00128415-200812230-00035

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812230-00035

Keywords

Search

Navigation